Pimethixene

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T46J20J26F, chemically known as piperidine, 1-methyl-4-thioxanthen-9-ylidene- but generally known as pimethixene, which bears US NIH Compound Identifier 4822. European Medicines Agency schedules Pimethixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09840MIG. The term PIMETHIXENE is an International Non-Proprietary Name. World Health Organization schedules pimethixene in its Anatomical Therapeutic Chemical (ATC) Classification. PIMETHIXENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pimethixene under HS 29349990 and SITC 51579. As of Q4 2014, PIMETHIXENE remains the US FDA Preferred Term for this commodity. Pimethixene bears US NLM identifiers UMLS ID C0071069 and NCI Concept Code C82276. SMILES: S1C2C(/C(=C3/CCN(CC3)C)C3C1CCCC3)CCCC2.